Current role
Biotechnology · Healthcare
Board Member
2025-09-08–present
Hervé Hoppenot
Board Member
Bicycle Therapeutics PLC (BCYC)Equibles does not estimate personal net worth.
Get an email with a short summary when Bicycle Therapeutics PLC publishes a filing, an earnings call transcript or a press release.
Get BCYC alertsAbout Hervé Hoppenot
Hervé Hoppenot is recorded as Board Member at Bicycle Therapeutics PLC (BCYC) since September 8, 2025. Bicycle Therapeutics PLC reported in an 8-K filed September 8, 2025 that Hervé Hoppenot was appointed Class I director, effective September 8, 2025. Bicycle Therapeutics PLC is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Bicycle Therapeutics PLC includes Kevin Lee (CEO and Board Member), Felix J. Baker, Ph.D. (Chairman and Board Member), Pierre Legault (Chairman) and 7 others.
“(ii) Hervé Hoppenot to the Board as a Class I director, for a term expiring at the Company's 2026 annual general meeting.”
Affiliation history
-
Current
2025-09-08–present
Company network
Leadership on record at Bicycle Therapeutics PLC
- Kevin Lee CEO, Board Member
- Felix J. Baker, Ph.D. Chairman, Board Member
- Pierre Legault Chairman
- Alethia Young CFO
- Travis Thompson CFO, Chief Accounting Officer
- Alistair Milnes COO
- Jennifer Perry COO
- Jennifer Perry, Pharm.D. COO
- Michael Skynner COO, CTO
- Alessandro Riva, M.D. Board Member